Development and validation of a new RP-HPLC Method for the simultaneous estimation of Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined dosage form

Development and validation of a new RP-HPLC Method for the simultaneous estimation of Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined dosage form

Registration ID: IJNRD_226834

Published ID: IJNRDTH00187

DOI: Click Here to Get

Aneesha Kappen , Satya V

Key Words: Lamivudine, Doravirine, Tenofovir disoproxil fumarate, RP-HPLC, method development, validation.

A new, simple, accurate and specific RP-HPLC method was developed for the simultaneous estimation of the Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined solid dosage form. The chromatogram was run through Kromasil C18 250x4.6mm, 5 column. Mobile phase containing a buffer and acetonitrile in the ratio of 60:40 v/v was pumped through the column at a flow rate of 1ml/min. Buffer used in this method was 0.1% OPA. Temperature of system was maintained at 30°C. The optimized wavelength for Lamivudine, Doravirine and Tenofovir disoproxil fumarate was 272.0 nm. Retention time of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were found to be 2.314 min, 4.616 min and 3.196 min. % RSD of system precision for Lamivudine, Doravirine and Tenofovir disoproxil fumarate were found to be 1.0, 0.9 and 1.0 respectively. % RSD of method precision for Lamivudine, Doravirine Tenofovir were found to be 0.5, 0.7 and 0.5 respectively. % Recovery was obtained as 99.57%, 99.89% and 99.74% for Lamivudine, Doravirine and Tenofovir disoproxil fumarate respectively. LOD values obtained from regression equations of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were 0.27 ppm, 0.09 ppm and 0.18 ppm, and LOQ values obtained from regression equations of Lamivudine, Doravirine and Tenofovir disoproxil fumarate were 0.82ppm, 0.28 ppm and 0.54ppm respectively. Regression equation of Lamivudine was y = 14959x + 1184, Doravirine was y = 28129x + 2766 and of Tenofovir was y = 17361x + 6030.

Published Paper   E-Certificate

"Development and validation of a new RP-HPLC Method for the simultaneous estimation of Lamivudine, Doravirine and Tenofovir disoproxil fumarate in combined dosage form ", IJNRD - INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (www.IJNRD.org), ISSN:2456-4184, Vol.9, Issue 8, page no.243-312, August-2024, Available :https://ijnrd.org/papers/IJNRDTH00187.pdf

Volume 9 Issue 8, August-2024

Pages : 243-312

Paper Reg. ID: IJNRD_226834

Published Paper Id: IJNRDTH00187

Downloads: 000121214

Research Area: Pharmacy

Country: Kasaragod DT, Kerala , India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00187.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00187

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave

This work is licensed under a Creative Commons Attribution 4.0 International License and The Open Definition

Call For Paper - Volume 10 | Issue 8 | August 2025

IJNRD is Scholarly open access journals, Peer-reviewed, and Refereed Journals, High Impact factor 8.76 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool), Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI) with Open-Access Publications.

INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to explore advances in research pertaining to applied, theoretical and experimental Technological studies. The goal is to promote scientific information interchange between researchers, developers, engineers, students, and practitioners working in and around the world. IJNRD will provide an opportunity for practitioners and educators of engineering field to exchange research evidence, models of best practice and innovative ideas.

Indexing In Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar | AI-Powered Research Tool, Microsoft Academic, Academia.edu, arXiv.org, Research Gate, CiteSeerX, ResearcherID Thomson Reuters, Mendeley : reference manager, DocStoc, ISSUU, Scribd, and many more

How to submit the paper?

Important Dates for Current issue

Paper Submission Open For: August 2025

Current Issue: Volume 10 | Issue 8

Last Date for Paper Submission: Till 31-Aug-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: International Peer-reviewed, Refereed, and Open Access Journal.

Subject Category: Research Area